James Gordon has given his Buy rating due to a combination of factors surrounding AstraZeneca’s position in the market and the assessment of their drug development pipeline. Firstly, despite the ...
UK shares ended higher on Monday, driven by gains in commodity-linked shares, particularly precious metal miners, amidst rising gold prices. Heavyweight energy shares also tracked elevated crude oil ...
Arab Finance: AstraZeneca Egypt is planning to inject $50 million into new investments in Egypt, equivalent to nearly 50% of the company’s capital, the firm’s Country President Hatem Werdany stated.
Some results have been hidden because they may be inaccessible to you